Difference between revisions of "Imetelstat (Rytelo)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "[http://www.geron.com/imetelstat link to company website] Category:Investigational Category:Telomerase inhibitors")
 
m
Line 1: Line 1:
[http://www.geron.com/imetelstat link to company website]
+
==Mechanism of action==
 +
A lipid-conjugated oligonucleotide inhibitor of human telomerase.
 +
[http://www.geron.com/imetelstat Link to company website]
 +
 
 +
==Preliminary data==
 +
# '''Abstract:''' Kebede Begna, Rebecca R. Laborde, Mrinal M Patnaik, Terra L Lasho, Darci Zblewski, Christy Finke, Lauren Schimek, Betsy R. LaPlant, Curtis A. Hanson, Monic J. Stuart, Animesh Pardanani. Imetelstat, a Telomerase Inhibitor, Induces Morphologic and Molecular Remissions In Myelofibrosis and Reversal Of Bone Marrow Fibrosis. Blood Nov 2013,122(21)662 [http://bloodjournal.hematologylibrary.org/content/122/21/662 link to original abstract]
  
 
[[Category:Investigational]]
 
[[Category:Investigational]]
 
[[Category:Telomerase inhibitors]]
 
[[Category:Telomerase inhibitors]]

Revision as of 16:02, 11 June 2014

Mechanism of action

A lipid-conjugated oligonucleotide inhibitor of human telomerase. Link to company website

Preliminary data

  1. Abstract: Kebede Begna, Rebecca R. Laborde, Mrinal M Patnaik, Terra L Lasho, Darci Zblewski, Christy Finke, Lauren Schimek, Betsy R. LaPlant, Curtis A. Hanson, Monic J. Stuart, Animesh Pardanani. Imetelstat, a Telomerase Inhibitor, Induces Morphologic and Molecular Remissions In Myelofibrosis and Reversal Of Bone Marrow Fibrosis. Blood Nov 2013,122(21)662 link to original abstract